Your browser doesn't support javascript.
loading
Accuracy of SARC-F and SARC-CalF for sarcopenia screening in older women from southern Brazil.
Mazocco, Letícia; Chagas, Patrícia; Barbosa-Silva, Thiago G; Gonzalez, Maria Cristina; Schwanke, Carla Helena Augustin.
Afiliação
  • Mazocco L; Graduate Program in Biomedical Gerontology, School of Medicine, Pontifical Catholic University of Rio Grande do Sul (PUCRS), Porto Alegre, Brazil.
  • Chagas P; Postgraduate Program in Gerontology, Federal University of Santa Maria (UFSM), Santa Maria, Brazil; Department of Food and Nutrition, Federal University of Santa Maria (UFSM), Palmeira das Missões, Brazil.
  • Barbosa-Silva TG; Faculty of Medicine, Catholic University of Pelotas (UCPel), Pelotas, Brazil; Faculty of Medicine, Federal University of Pelotas (UFPel), Pelotas, Brazil.
  • Gonzalez MC; Postgraduate Program in Health and Behavior, Catholic University of Pelotas (UCPel), Pelotas, Brazil.
  • Schwanke CHA; Graduate Program in Biomedical Gerontology, School of Medicine, Pontifical Catholic University of Rio Grande do Sul (PUCRS), Porto Alegre, Brazil; Institute of Geriatrics and Gerontology, Pontifical Catholic University of Rio Grande do Sul (PUCRS), Porto Alegre, Brazil. Electronic address: schwanke@
Nutrition ; 79-80: 110955, 2020.
Article em En | MEDLINE | ID: mdl-32919183
OBJECTIVES: The aim of this study was to verify the accuracy of the SARC-F and the SARC-CalF as screening tools for sarcopenia in community-dwelling older women ≥60 y of age. METHODS: This was a cross-sectional study evaluating a convenience sample of women ≥60 y of age, living in Southern Brazil. Sarcopenia was defined according to the criteria proposed in the latest European Working Group on Sarcopenia in Older People consensus (EWGSOP2). Appendicular muscle mass was assessed by dual-energy x-ray absorptiometry. Muscle strength was measured by handheld dynamometry, and physical performance through the 4-m gait speed test. The SARC-F questionnaire and SARC-CalF score for sarcopenia screening were also applied. RESULTS: We evaluated 288 participants, with a mean age of 67.6 ± 5.8 y. The frequency of probable and confirmed sarcopenia in the sample was 7.3% and 2.1%, respectively. The frequency of risk for sarcopenia assessed by the SARC-F was 4.5% and SARC-CalF 22.2%. Despite the excellent specificity (95.4%) demonstrated by the SARC-F, its sensitivity in identifying confirmed cases was null, whereas the SARC-CalF showed high sensitivity (83.3%) and good specificity (79%). CONCLUSION: The present study findings suggested that SARC-CalF may be able to outperform SARC-F as a sarcopenia screening tool in women ≥60 y of age even under the new EWGSOP2 criteria, the main determinant of which is strength as observed in studies based on the previous definition.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sarcopenia Tipo de estudo: Diagnostic_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Aged / Female / Humans País/Região como assunto: America do sul / Brasil Idioma: En Revista: Nutrition Assunto da revista: CIENCIAS DA NUTRICAO Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Brasil País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sarcopenia Tipo de estudo: Diagnostic_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Aged / Female / Humans País/Região como assunto: America do sul / Brasil Idioma: En Revista: Nutrition Assunto da revista: CIENCIAS DA NUTRICAO Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Brasil País de publicação: Estados Unidos